Does CLOPIDOGREL BISULFATE Cause Mobility decreased? 158 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 158 reports of Mobility decreased have been filed in association with CLOPIDOGREL BISULFATE (Clopidogrel). This represents 0.3% of all adverse event reports for CLOPIDOGREL BISULFATE.
158
Reports of Mobility decreased with CLOPIDOGREL BISULFATE
0.3%
of all CLOPIDOGREL BISULFATE reports
2
Deaths
132
Hospitalizations
How Dangerous Is Mobility decreased From CLOPIDOGREL BISULFATE?
Of the 158 reports, 2 (1.3%) resulted in death, 132 (83.5%) required hospitalization, and 21 (13.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOPIDOGREL BISULFATE. However, 158 reports have been filed with the FAERS database.
What Other Side Effects Does CLOPIDOGREL BISULFATE Cause?
Gastrointestinal haemorrhage (5,513)
Anaemia (3,043)
Dyspnoea (1,963)
Drug interaction (1,846)
Haemorrhage (1,762)
Drug ineffective (1,644)
Cerebral haemorrhage (1,603)
Dizziness (1,586)
Epistaxis (1,560)
Melaena (1,547)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which CLOPIDOGREL BISULFATE Alternatives Have Lower Mobility decreased Risk?
CLOPIDOGREL BISULFATE vs CLORAZEPATE
CLOPIDOGREL BISULFATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN
CLOPIDOGREL BISULFATE vs CLOTHIAPINE
CLOPIDOGREL BISULFATE vs CLOTIAZEPAM
CLOPIDOGREL BISULFATE vs CLOTRIMAZOLE